Wip1-dependent signaling pathways in health and diseases

Progress in Molecular Biology and Translational Science

Volumn 106, Issue , 2012, Pages 307-325

  Zhu, Yun Hua ^a   Bulavin, Dmitry V ^a  

^a INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Singapore)

Author keywords

Aging; ATM; Neural stem cell; Neurogenesis; p38; p53; PP2C ; Ppm1d; Progenitors; Tumorigenesis; Wip1 phosphatase

Indexed keywords

EID: 84863164879     PISSN: 18771173     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-396456-4.00001-8     Document Type: Chapter

References (95)

1. T. Lammers, and S. Lavi Role of type 2C protein phosphatases in growth regulation and in cellular stress signaling Crit Rev Biochem Mol Biol 42 2007 437 461 (Pubitemid 350232897)
2. T. Sugiura, Y. Noguchi, K. Sakurai, and C. Hattori Protein phosphatase 1H, overexpressed in colon adenocarcinoma, is associated with CSE1L Cancer Biol Ther 7 2008 285 292 (Pubitemid 351590438)
3. M. Fiscella, H. Zhang, S. Fan, K Sakaguchi, S Shen, and M.E. Mercer Wip1, a novel human protein phosphatase that is induced in response to ionizing radiation in a p53-dependent manner Proc Natl Acad Sci USA 94 1997 6048 6053 (Pubitemid 27270633)
4. E.S. Wong, X. Le Guezennec, O.N. Demidov, N.T. Marshall, S.T. Wang, and J Krishnamurthy p38MAPK controls expression of multiple cell cycle inhibitors and islet proliferation with advancing age Dev Cell 17 2009 142 149
5. Y.H. Zhu, C.W. Zhang, L. Lu, O.N. Demidov, L. Sun, and L. Yang Wip1 regulates the generation of new neural cells in the adult olfactory bulb through p53-dependent cell cycle control Stem Cells 27 2009 1433 1442
6. X. Le Guezennec, and D.V. Bulavin WIP1 phosphatase at the crossroads of cancer and aging Trends Biochem Sci 35 2010 109 114
7. J. Choi, E. Appella, and L.A. Donehower The structure and expression of the murine wildtype p53-induced phosphatase 1 (Wip1) gene Genomics 64 2000 298 306 (Pubitemid 30212630)
8. Y. Chuman, W. Kurihashi, Y. Mizukami, T. Nashimoto, H. Yagi, and K. Sakaguchi PPM1D430, a novel alternative splicing variant of the human PPM1D, can dephosphorylate p53 and exhibits specific tissue expression J Biochem 145 2009 1 12
9. M. Takekawa, M. Adachi, A. Nakahata, I. Nakayama, F. Itoh, and H. Tsukuda p53-inducible wip1 phosphatase mediates a negative feedback regulation of p38 MAPK-p53 signaling in response to UV radiation EMBO J 19 2000 6517 6526
10. S. Shreeram, O.N. Demidov, W.K. Hee, H Yamaguchi, N. Onishi, and C. Kek Wip1 phosphatase modulates ATM-dependent signaling pathways Mol Cell 23 2006 757 764 (Pubitemid 44308587)
11. E. Batchelor, C.S. Mock, I. Bhan, A. Loewer, and G. Lahav Recurrent initiation: a mechanism for triggering p53 pulses in response to DNA damage Mol Cell 30 2008 277 289 (Pubitemid 351615316)
12. H. Fujimoto, N. Onishi, N. Kato, M Takekawa, X.Z. Xu, and A. Kosugi Regulation of the antioncogenic Chk2 kinase by the oncogenic Wip1 phosphatase Cell Death Differ 13 2006 1170 1180 (Pubitemid 43905597)
13. X. Lu, O. Ma, T.A. Nguyen, S.N. Jones, M. Oren, and L.A. Donehower The Wip1 phosphatase acts as a gatekeeper in the p53-Mdm2 autoregulatory loop Cancer Cell 12 2007 342 354 (Pubitemid 47539308)
14. X. Zhang, L. Lin, H. Guo, J. Yang, S.N. Jones, and A. Jochemsen Phosphorylation and degradation of MdmX is inhibited by Wip1 phosphatase in the DNA damage response Cancer Res 69 2009 7960 7968
15. H. Cha, J.M. Lowe, H. Li, J.S. Lee, G.I. Belova, and D.V. Bulavin Wip1 directly dephosphorylates gamma-H2AX and attenuates the DNA damage response Cancer Res 70 2010 4112 4122
16. L. Macurek, A. Lindqvist, O. Voets, J Kool, H.R. Vos, and R.H. Medema Wip1 phosphatase is associated with chromatin and dephosphorylates gammaH2AX to promote checkpoint inhibition Oncogene 29 2010 2281 2291
17. S.H. Moon, T.A. Nguyen, Y. Darlington, X. Lu, and L.A. Donehower Dephosphorylation of gamma-H2AX by WIP1: an important homeostatic regulatory event in DNA repair and cell cycle control Cell Cycle 9 2010 2092 2096
18. J. Choi, B. Nannenga, O.N. Demidov, D.V. Bulavin, A. Cooney, and C. Brayton Mice deficient for the wild-type p53-induced phosphatase gene (Wip1) exhibit defects in reproductive organs, immune function, and cell cycle control Mol Cell Biol 22 2002 1094 1105 (Pubitemid 34094846)
19. D. Hanahan, and R.A. Weinberg Hallmarks of cancer: the next generation Cell 144 2011 646 674
20. A. Sancar, L.A. Lindsey-Boltz, K. Unsal-Kacmaz, and S. Linn Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints Annu Rev Biochem 73 2004 39 85 (Pubitemid 39050363)
21. J. Li, Y. Yang, Y. Peng, R.J. Austin, W.G. van Eyndhoven, and K.C. Nguyen Oncogenic properties of PPM1D located within a breast cancer amplification epicenter at 17q23 Nat Genet 31 2002 133 134
22. D.V. Bulavin, O.N. Demidov, S. Saito, P. Kauraniemi, C. Phillips, and S.A. Amundson Amplification of PPM1D in human tumors abrogates p53 tumor-suppressor activity Nat Genet 31 2002 210 215
23. O.N. Demidov, C. Kek, S. Shreeram, O. Timofeev, A.J. Fornace, and E. Appella The role of the MKK6/p38 MAPK pathway in Wip1-dependent regulation of ErbB2-driven mammary gland tumorigenesis Oncogene 26 2007 2502 2506 (Pubitemid 46597262)
24. C.S. Sinclair, M. Rowley, A. Naderi, and F.J. Couch The 17q23 amplicon and breast cancer Breast Cancer Res Treat 78 2003 313 322 (Pubitemid 36543211)
25. M. Barlund, T. Kuukasjarvi, K. Syrjakoski, A. Auvinen, and A. Kallioniemi Frequent amplification and overexpression of CCND1 in male breast cancer Int J Cancer 111 2004 968 971 (Pubitemid 39096248)
26. R. Natrajan, M.B. Lambros, S.M. Rodriguez-Pinilla, G Moreno-Bueno, D.S. Tan, and C. Marchio Tiling path genomic profiling of grade 3 invasive ductal breast cancers Clin Cancer Res 15 2009 2711 2722
27. F. Saito-Ohara, I. Imoto, J. Inoue, H Hosoi, A Nakagawara, and T Sugimoto PPM1D is a potential target for 17q gain in neuroblastoma Cancer Res 63 2003 1876 1883 (Pubitemid 36460852)
28. F. Mendrzyk, B. Radlwimmer, S. Joos, F. Kokocinski, A. Benner, and D.E. Stange Genomic and protein expression profiling identifies CDK6 as novel independent prognostic marker in medulloblastoma J Clin Oncol 23 2005 8853 8862 (Pubitemid 46211532)
29. R.C. Castellino, M. De Bortoli, X. Lu, S.H. Moon, T.A. Nguyen, and M.A. Shepard Medulloblastomas overexpress the p53-inactivating oncogene WIP1/PPM1D J Neurooncol 86 2008 245 256
30. A. Ehrbrecht, U. Muller, M. Wolter, A. Hoischen, A. Koch, and B. Radlwimmer Comprehensive genomic analysis of desmoplastic medulloblastomas: identification of novel amplified genes and separate evaluation of the different histological components J Pathol 208 2006 554 563 (Pubitemid 43329342)
31. D.S. Tan, M.B. Lambros, S. Rayter, R. Natrajan, R. Vatcheva, and Q. Gao PPM1D is a potential therapeutic target in ovarian clear cell carcinomas Clin Cancer Res 15 2009 2269 2280
32. A. Hirasawa, F. Saito-Ohara, J. Inoue, D. Aoki, N. Susumu, and T. Yokoyama Association of 17q21-q24 gain in ovarian clear cell adenocarcinomas with poor prognosis and identification of PPM1D and APPBP2 as likely amplification targets Clin Cancer Res 9 2003 1995 2004 (Pubitemid 36687618)
33. T. Fuku, S. Semba, H. Yutori, and H. Yokozaki Increased wild-type p53-induced phosphatase 1 (Wip1 or PPM1D) expression correlated with downregulation of checkpoint kinase 2 in human gastric carcinoma Pathol Int 57 2007 566 571 (Pubitemid 47222705)
34. P. Loukopoulos, T. Shibata, H. Katoh, A. Kokubu, M. Sakamoto, and K. Yamazaki Genome-wide array-based comparative genomic hybridization analysis of pancreatic adenocarcinoma: identification of genetic indicators that predict patient outcome Cancer Sci 98 2007 392 400 (Pubitemid 46195611)
35. M. Lopez-Guerra, L. Trigueros-Motos, M. Molina-Arcas, N. Villamor, F.J. Casado, and E. Montserrat Identification of TIGAR in the equilibrative nucleoside transporter 2-mediated response to fludarabine in chronic lymphocytic leukemia cells Haematologica 93 2008 1843 1851
36. E. Yu, Y.S. Ahn, S.J. Jang, M.J. Kim, H.S. Yoon, and G. Gong Overexpression of the wip1 gene abrogates the p38 MAPK/p53/Wip1 pathway and silences p16 expression in human breast cancers Breast Cancer Res Treat 101 2007 269 278 (Pubitemid 46169880)
37. J. Rauta, E.L. Alarmo, P. Kauraniemi, R. Karhu, T. Kuukasjarvi, and A. Kallioniemi The serine-threonine protein phosphatase PPM1D is frequently activated through amplification in aggressive primary breast tumours Breast Cancer Res Treat 95 2006 257 263
38. M. Harrison, J. Li, Y. Degenhardt, T. Hoey, and S. Powers Wip1-deficient mice are resistant to common cancer genes Trends Mol Med 10 2004 359 361 (Pubitemid 39061135)
39. D.V. Bulavin, C. Phillips, B. Nannenga, O. Timofeev, L.A. Donehower, and C.W. Anderson Inactivation of the Wip1 phosphatase inhibits mammary tumorigenesis through p38 MAPK-mediated activation of the p16(Ink4a)-p19(Arf) pathway Nat Genet 36 2004 343 350 (Pubitemid 38437256)
40. B. Nannenga, X. Lu, M. Dumble, M. Van Maanen, T.A. Nguyen, and R. Sutton Augmented cancer resistance and DNA damage response phenotypes in PPM1D null mice Mol Carcinog 45 2006 594 604 (Pubitemid 44205099)
41. D.V. Bulavin, and A.J. Fornace Jr. p38 MAP kinase's emerging role as a tumor suppressor Adv Cancer Res 92 2004 95 118 (Pubitemid 39458114)
42. J.J. Ventura, S. Tenbaum, E. Perdiguero, M. Huth, C. Guerra, and M. Barbacid p38alpha MAP kinase is essential in lung stem and progenitor cell proliferation and differentiation Nat Genet 39 2007 750 758 (Pubitemid 46848588)
43. L. Hui, L. Bakiri, A. Mairhorfer, N. Schweifer, C. Haslinger, and L. Kenner p38alpha suppresses normal and cancer cell proliferation by antagonizing the JNK-c-Jun pathway Nat Genet 39 2007 741 749 (Pubitemid 46848584)
44. S. Shreeram, W.K. Hee, O.N. Demidov, C. Kek, H. Yamaguchi, and A.J. Fornace Jr. Regulation of ATM/p53-dependent suppression of myc-induced lymphomas by Wip1 phosphatase J Exp Med 203 2006 2793 2799 (Pubitemid 46026157)
45. O.N. Demidov, O. Timofeev, H.N. Lwin, C. Kek, E. Appella, and D.V. Bulavin Wip1 phosphatase regulates p53-dependent apoptosis of stem cells and tumorigenesis in the mouse intestine Cell Stem Cell 1 2007 180 190 (Pubitemid 47215589)
46. H. Takai, K. Naka, Y. Okada, M. Watanabe, N. Harada, and S. Saito Chk2-deficient mice exhibit radioresistance and defective p53-mediated transcription EMBO J 21 2002 5195 5205
47. X.P. Zhang, F. Liu, and W. Wang Two-phase dynamics of p53 in the DNA damage response Proc Natl Acad Sci USA 108 2011 8990 8995
48. X. Lu, T.A. Nguyen, and L.A. Donehower Reversal of the ATM/ATR-mediated DNA damage response by the oncogenic phosphatase PPM1D Cell Cycle 4 2005 1060 1064 (Pubitemid 41365366)
49. J.P. Reddy, S. Peddibhotla, W. Bu, J. Zhao, S. Haricharan, and Y.C. Du Defining the ATM-mediated barrier to tumorigenesis in somatic mammary cells following ErbB2 activation Proc Natl Acad Sci USA 107 2010 3728 3733
50. J. Bartkova, Z. Horejsi, K. Koed, A. Kramer, F. Tort, and K. Zieger DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis Nature 434 2005 864 870 (Pubitemid 40558993)
51. J. Bartek, J. Bartkova, and J. Lukas DNA damage signalling guards against activated oncogenes and tumour progression Oncogene 26 2007 7773 7779 (Pubitemid 350242463)
52. K. Oka, T. Tanaka, T. Enoki, K. Yoshimura, M. Ohshima, and M. Kubo DNA damage signaling is activated during cancer progression in human colorectal carcinoma Cancer Biol Ther 9 2010 246 252
53. R. Cipriano, C.E. Kan, J. Graham, D. Danielpour, M. Stampfer, and M.W. Jackson TGF-{beta} signaling engages an ATM-CHK2-p53-independent RAS-induced senescence and prevents malignant transformation in human mammary epithelial cells Proc Natl Acad Sci USA 108 2011 8668 8673
54. P. Wang, T.C. Greiner, T. Lushnikova, and C.M. Eischen Decreased Mdm2 expression inhibits tumor development induced by loss of ARF Oncogene 25 2006 3708 3718 (Pubitemid 43980492)
55. D.K. Ma, M.A. Bonaguidi, G.L. Ming, and H. Song Adult neural stem cells in the mammalian central nervous system Cell Res 19 2009 672 682
56. G.L. Ming, and H. Song Adult neurogenesis in the mammalian central nervous system Annu Rev Neurosci 28 2005 223 250 (Pubitemid 41098905)
57. P. Taupin Adult neurogenesis in the mammalian central nervous system: functionality and potential clinical interest Med Sci Monit 11 2005 RA247 RA252
58. O. Arias-Carrion, and T.F. Yuan Autologous neural stem cell transplantation: a new treatment option for Parkinson's disease? Med Hypotheses 73 5 2009 757 759
59. K. Muraoka, T. Shingo, T. Yasuhara, M. Kameda, W. Yuan, and H. Hayase The high integration and differentiation potential of autologous neural stem cell transplantation compared with allogeneic transplantation in adult rat hippocampus Exp Neurol 199 2006 311 327 (Pubitemid 43928959)
60. D.C. Lie, H. Song, S.A. Colamarino, G.L. Ming, and F.H. Gage Neurogenesis in the adult brain: new strategies for central nervous system diseases Annu Rev Pharmacol Toxicol 44 2004 399 421 (Pubitemid 38263847)
61. G. Gheusi, H. Cremer, H. McLean, G. Chazal, J.D. Vincent, and P.M. Lledo Importance of newly generated neurons in the adult olfactory bulb for odor discrimination Proc Natl Acad Sci USA 97 2000 1823 1828 (Pubitemid 30118527)
62. E. Bruel-Jungerman, C. Rampon, and S. Laroche Adult hippocampal neurogenesis, synaptic plasticity and memory: facts and hypotheses Rev Neurosci 18 2007 93 114
63. M.A. Curtis, P.S. Eriksson, and R.L. Faull Progenitor cells and adult neurogenesis in neurodegenerative diseases and injuries of the basal ganglia Clin Exp Pharmacol Physiol 34 2007 528 532 (Pubitemid 46494484)
64. M.A. Curtis, R.L. Faull, and P.S. Eriksson The effect of neurodegenerative diseases on the subventricular zone Nat Rev Neurosci 8 2007 712 723 (Pubitemid 47283148)
65. C.M. Morshead, C.G. Craig, and D. van der Kooy In vivo clonal analyses reveal the properties of endogenous neural stem cell proliferation in the adult mammalian forebrain Development 125 1998 2251 2261 (Pubitemid 28336386)
66. K. Meletis, V. Wirta, S.M. Hede, M. Nister, J. Lundeberg, and J. Frisen p53 suppresses the self-renewal of adult neural stem cells Development 133 2006 363 369 (Pubitemid 43210724)
67. S. Gil-Perotin, M. Marin-Husstege, J. Li, M. Soriano-Navarro, F. Zindy, and M.F. Roussel Loss of p53 induces changes in the behavior of subventricular zone cells: implication for the genesis of glial tumors J Neurosci 26 2006 1107 1116 (Pubitemid 43237042)
68. S. Medrano, M. Burns-Cusato, M.B. Atienza, D. Rahimi, and H. Scrable Regenerative capacity of neural precursors in the adult mammalian brain is under the control of p53 Neurobiol Aging 30 2009 483 497
69. D.J. Rossi, C.H. Jamieson, and I.L. Weissman Stems cells and the pathways to aging and cancer Cell 132 2008 681 696 (Pubitemid 351253688)
70. P.A. Beachy, S.S. Karhadkar, and D.M. Berman Tissue repair and stem cell renewal in carcinogenesis Nature 432 2004 324 331 (Pubitemid 39551660)
71. H. Zheng, H. Ying, H. Yan, A.C. Kimmelman, D.J. Hiller, and A.J. Chen p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation Nature 455 2008 1129 1133
72. H. Zheng, H. Ying, H. Yan, A.C. Kimmelman, D.J. Hiller, and A.J. Chen Pten and p53 converge on c-Myc to control differentiation, self-renewal, and transformation of normal and neoplastic stem cells in glioblastoma Cold Spring Harb Symp Quant Biol 73 2008 427 437
73. S. Alcantara Llaguno, J. Chen, C.H. Kwon, E.L. Jackson, Y. Li, and D.K. Burns Malignant astrocytomas originate from neural stem/progenitor cells in a somatic tumor suppressor mouse model Cancer Cell 15 2009 45 56
74. C.H. Kwon, D. Zhao, J. Chen, S. Alcantara, Y. Li, and D.K. Burns Pten haploinsufficiency accelerates formation of high-grade astrocytomas Cancer Res 68 2008 3286 3294
75. M. Groszer, R. Erickson, D.D. Scripture-Adams, J.D. Dougherty, J. Le Belle, and J.A. Zack PTEN negatively regulates neural stem cell self-renewal by modulating G0-G1 cell cycle entry Proc Natl Acad Sci USA 103 2006 111 116 (Pubitemid 43076113)
76. R.M. Bachoo, E.A. Maher, K.L. Ligon, N.E. Sharpless, S.S. Chan, and M.J. You Epidermal growth factor receptor and Ink4a/Arf: convergent mechanisms governing terminal differentiation and transformation along the neural stem cell to astrocyte axis Cancer Cell 1 2002 269 277 (Pubitemid 41039151)
77. N. Sanai, A. Alvarez-Buylla, and M.S. Berger Neural stem cells and the origin of gliomas N Engl J Med 353 2005 811 822
78. G. Dontu, S. Liu, and M.S. Wicha Stem cells in mammary development and carcinogenesis: implications for prevention and treatment Stem Cell Rev 1 2005 207 213
79. A.V. Molofsky, S.G. Slutsky, N.M. Joseph, S. He, R. Pardal, and J. Krishnamurthy Increasing p16INK4a expression decreases forebrain progenitors and neurogenesis during ageing Nature 443 2006 448 452 (Pubitemid 44477280)
80. M. Nagao, K. Campbell, K. Burns, C.Y. Kuan, A. Trumpp, and M. Nakafuku Coordinated control of self-renewal and differentiation of neural stem cells by Myc and the p19ARF-p53 pathway J Cell Biol 183 2008 1243 1257
81. J. Nishino, I. Kim, K. Chada, and S.J. Morrison Hmga2 promotes neural stem cell self-renewal in young but not old mice by reducing p16Ink4a and p19Arf Expression Cell 135 2008 227 239
82. V. Janzen, R. Forkert, H.E. Fleming, Y. Saito, M.T. Waring, and D.M. Dombkowski Stem-cell ageing modified by the cyclin-dependent kinase inhibitor p16INK4a Nature 443 2006 421 426 (Pubitemid 44477274)
83. J. Krishnamurthy, M.R. Ramsey, K.L. Ligon, C. Torrice, A. Koh, and S. Bonner-Weir p16INK4a induces an age-dependent decline in islet regenerative potential Nature 443 2006 453 457 (Pubitemid 44477281)
84. A.P. Ugalde, A.J. Ramsay, J. de la Rosa, I. Varela, G. Marino, and J. Cadinanos Aging and chronic DNA damage response activate a regulatory pathway involving miR-29 and p53 EMBO J 30 2011 2219 2232
85. A. Freund, C.K. Patil, and J. Campisi p38MAPK is a novel DNA damage response-independent regulator of the senescence-associated secretory phenotype EMBO J 30 2011 1536 1548
86. J.S. Lee, M.O. Lee, B.H. Moon, S.H. Shim, A.J. Fornace Jr., and H.J. Cha Senescent growth arrest in mesenchymal stem cells is bypassed by Wip1-mediated downregulation of intrinsic stress signaling pathways Stem Cells 27 8 2009 1963 1975
87. E. Wong, X. Le Guezennec, S.T. Wang, J. Krishnamurthy, N.R. Dunn, and N.E. Sharpless p38MAPK signalling induces Ink4a/Arf expression with aging Dev Cell 17 2009 142 149
88. D.V. Bulavin, S. Saito, M.C. Hollander, K. Sakaguchi, C.W. Anderson, and E. Appella Phosphorylation of human p53 by p38 kinase coordinates N-terminal phosphorylation and apoptosis in response to UV radiation EMBO J 18 1999 6845 6854
89. J. Kim, and P.K.Y. Wong Loss of ATM impairs proliferation of neural stem cells through oxidative stress-mediated p38 MAPK signaling Stem Cells 27 8 2009 1987 1998
90. A. Keren, Y. Tamir, and E. Bengal The p38 MAPK signaling pathway: a major regulator of skeletal muscle development Mol Cell Endocrinol 252 2006 224 230
91. A. Lindqvist, M. de Bruijn, L. Macurek, A. Bras, A. Mensinga, and W. Bruinsma Wip1 confers G2 checkpoint recovery competence by counteracting p53-dependent transcriptional repression EMBO J 28 2009 3196 3206
92. M.C. Maiuri, L. Galluzzi, E. Morselli, O. Kepp, S.A. Malik, and G. Kroemer Autophagy regulation by p53 Curr Opin Cell Biol 22 2010 181 185
93. G.M. Balaburski, R.D. Hontz, and M.E. Murphy p53 and ARF: unexpected players in autophagy Trends Cell Biol 20 2010 363 369
94. M. Oliva-Trastoy, V. Berthonaud, A. Chevalier, C. Ducrot, M.C. Marsolier-Kergoat, and C. Mann The Wip1 phosphatase (PPM1D) antagonizes activation of the Chk2 tumour suppressor kinase Oncogene 26 2007 1449 1458 (Pubitemid 46340814)
95. J. Chew, S. Biswas, S. Shreeram, M. Humaidi, E.T. Wong, and M.K. Dhillion WIP1 phosphatase is a negative regulator of NF-kappaB signalling Nat Cell Biol 11 2009 659 666